Role of Monocyte Count and Neutrophil-to-Lymphocyte Ratio in Survival of Oral Cancer Patients

 

 Permissions and Reprints

Abstract

Introduction Inflammation seems to play a critical role in the development and progression of numerous cancers. Peripheral blood leukocyte count is an easily assessable parameter of systemic inflammatory response.

Objective The aim of this study was to investigate whether the pretreatment leukocyte counts can predict the prognosis of patients with oral cavity cancer.

Methods Medical records of 471 oral cavity cancer patients diagnosed between January 2007 and December 2008 were retrospectively analyzed. Receiver operating characteristic curve analysis and Cox proportional hazards analyses were applied to evaluate the associations of leukocyte counts with overall survival.

Results The overall five year's survival of the cohort was found to be 49.4%. On univariate analysis, elevated monocyte count (≥500/mm3) and neutrophil-to-lymphocyte ratio (NLR) (>2.38) were associated with poor overall survival (OS) (p = 0.001 and 0.000, respectively). Multivariate Cox proportional hazard analysis showed that higher monocyte and NLR levels were significant independent predictors of worse OS (HR = 1.385, 95% CI = 1.049 - 1.829; p < 0.05 and HR = 1.392, 95% CI = 1.045 - 1.855; p < 0.05, respectively). The advanced overall stage and lymph nodal involvement were also independent indicators for poor OS.

Conclusions Higher pretreatment monocyte and NLR levels are independent predictors of poor prognosis for patients with oral cavity cancer. Thus, these easily accessed variables can serve as a potent marker to predict the outcomes of oral cancer patients.

• References

• 1 Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2012, Cancer incidence and mortality worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2012. . Available at http://globocan.iarc.fr . Accessed on Dec 12, 2015
  Google Scholar
• 2 Sankaranarayanan R, Swaminathan R, Lucas E. Cancer survival in Africa, Asia, Caribbean and Central America: SURVCAN. Lyon, France: IARC Scientific publication international agency for research on cancer; 2010
  Google Scholar
• 3 Weitzman SA, Gordon LI. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 1990; 76 (4) 655-663
  CrossrefPubMedGoogle Scholar
• 4 Jarnicki A, Putoczki T, Ernst M. Stat3: linking inflammation to epithelial cancer: More than a “gut” feeling?. Cell Div 2010; 5: 14
  CrossrefPubMedGoogle Scholar
• 5 Kao SC, Pavlakis N, Harvie R , et al. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res 2010; 16 (23) 5805-5813
  CrossrefPubMedGoogle Scholar
• 6 Tsai YD, Wang CP, Chen CY , et al. Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer. Head Neck 2014; 36 (7) 947-953
  CrossrefPubMedGoogle Scholar
• 7 Perisanidis C, Kornek G, Pöschl PW , et al. High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer. Med Oncol 2013; 30 (1) 334-335
  CrossrefPubMedGoogle Scholar
• 8 Hornychova H, Melichar B, Tomsova M, Mergancova J, Urminska H, Ryska A. Tumor-infiltrating lymphocytes predict response to neoadjuvant chemotherapy in patients with breast carcinoma. Cancer Invest 2008; 26 (10) 1024-1031
  CrossrefPubMedGoogle Scholar
• 9 Bruckner HW, Lavin PT, Plaxe SC, Storch JA, Livstone EM. Absolute granulocyte, lymphocyte, and moncyte counts. Useful determinants of prognosis for patients with metastatic cancer of the stomach. JAMA 1982; 247 (7) 1004-1006
  CrossrefPubMedGoogle Scholar
• 10 Chew V, Chen J, Lee D , et al. Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma. Gut 2012; 61 (3) 427-438
  CrossrefPubMedGoogle Scholar
• 11 Koh YW, Kang HJ, Park C , et al. The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages. Oncologist 2012; 17 (6) 871-880
  CrossrefPubMedGoogle Scholar
• 12 Tibaldi C, Vasile E, Bernardini I, Orlandini C, Andreuccetti M, Falcone A. Baseline elevated leukocyte count in peripheral blood is associated with poor survival in patients with advanced non-small cell lung cancer: a prognostic model. J Cancer Res Clin Oncol 2008; 134 (10) 1143-1149
  CrossrefPubMedGoogle Scholar
• 13 Greene FL. The American Joint Committee on Cancer: updating the strategies in cancer staging. Bull Am Coll Surg 2002; 87 (7) 13-15
  PubMedGoogle Scholar
• 14 Greene FL, Sobin LH. The staging of cancer: a retrospective and prospective appraisal. CA Cancer J Clin 2008; 58 (3) 180-190
  CrossrefPubMedGoogle Scholar
• 15 Nakamura Y, Gindhart TD, Winterstein D, Tomita I, Seed JL, Colburn NH. Early superoxide dismutase-sensitive event promotes neoplastic transformation in mouse epidermal JB6 cells. Carcinogenesis 1988; 9 (2) 203-207
  CrossrefPubMedGoogle Scholar
• 16 Hussain SP, Aguilar F, Amstad P, Cerutti P. Oxy-radical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene. Oncogene 1994; 9 (8) 2277-2281
  PubMedGoogle Scholar
• 17 Baatenburg de Jong RJ, Hermans J, Molenaar J, Briaire JJ, le Cessie S. Prediction of survival in patients with head and neck cancer. Head Neck 2001; 23 (9) 718-724
  CrossrefPubMedGoogle Scholar
• 18 Sayed SI, Sharma S, Rane P , et al. Can metastatic lymph node ratio (LNR) predict survival in oral cavity cancer patients?. J Surg Oncol 2013; 108 (4) 256-263
  CrossrefPubMedGoogle Scholar
• 19 Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 2010; 6 (1) 149-163
  CrossrefPubMedGoogle Scholar
• 20 Sasaki A, Iwashita Y, Shibata K, Matsumoto T, Ohta M, Kitano S. Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma. Surgery 2006; 139 (6) 755-764
  CrossrefPubMedGoogle Scholar
• 21 Sasaki A, Kai S, Endo Y , et al. Prognostic value of preoperative peripheral blood monocyte count in patients with colorectal liver metastasis after liver resection. J Gastrointest Surg 2007; 11 (5) 596-602
  CrossrefPubMedGoogle Scholar
• 22 Bishara S, Griffin M, Cargill A , et al. Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancer. Eur J Obstet Gynecol Reprod Biol 2008; 138 (1) 71-75
  CrossrefPubMedGoogle Scholar
• 23 Anand M, Chodda SK, Parikh PM, Nadkarni JS. Abnormal levels of proinflammatory cytokines in serum and monocyte cultures from patients with chronic myeloid leukemia in different stages, and their role in prognosis. Hematol Oncol 1998; 16 (4) 143-154
  CrossrefPubMedGoogle Scholar
• 24 Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4 (1) 71-78
  CrossrefGoogle Scholar
• 25 Hefler L, Tempfer C, Heinze G , et al. Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients. Br J Cancer 1999; 81 (5) 855-859
  CrossrefPubMedGoogle Scholar
• 26 Dirkx AE, Oude Egbrink MG, Wagstaff J, Griffioen AW. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. J Leukoc Biol 2006; 80 (6) 1183-1196
  CrossrefPubMedGoogle Scholar
• 27 Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006; 66 (2) 605-612
  CrossrefPubMedGoogle Scholar
• 28 Halazun KJ, Aldoori A, Malik HZ , et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 2008; 34 (1) 55-60
  CrossrefPubMedGoogle Scholar
• 29 Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91 (3) 181-184
  CrossrefPubMedGoogle Scholar
• 30 Gomez D, Morris-Stiff G, Toogood GJ, Lodge JP, Prasad KR. Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol 2008; 97 (6) 513-518
  CrossrefPubMedGoogle Scholar
• 31 Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 2009; 137 (2) 425-428
  CrossrefPubMedGoogle Scholar
• 32 Wang DS, Luo HY, Qiu MZ , et al. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol 2012; 29 (5) 3092-3100
  CrossrefPubMedGoogle Scholar
• 33 He JR, Shen GP, Ren ZF , et al. Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck 2012; 34 (12) 1769-1776
  CrossrefPubMedGoogle Scholar
• 34 An X, Ding PR, Wang FH, Jiang WQ, Li YH. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma. Tumour Biol 2011; 32 (2) 317-324
  CrossrefPubMedGoogle Scholar
• 35 Azab B, Bhatt VR, Phookan J , et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol 2012; 19 (1) 217-224
  CrossrefPubMedGoogle Scholar
• 36 Motomura T, Shirabe K, Mano Y , et al. Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol 2013; 58 (1) 58-64
  CrossrefPubMedGoogle Scholar
• 37 McCourt M, Wang JH, Sookhai S, Redmond HP. Proinflammatory mediators stimulate neutrophil-directed angiogenesis. Arch Surg 1999; 134 (12) 1325-1331 , discussion 1331–1332
  CrossrefGoogle Scholar
• 38 McCourt M, Wang JH, Sookhai S, Redmond HP. Activated human neutrophils release hepatocyte growth factor/scatter factor. Eur J Surg Oncol 2001; 27 (4) 396-403
  CrossrefPubMedGoogle Scholar
• 39 Jabłońska E, Kiluk M, Markiewicz W, Piotrowski L, Grabowska Z, Jabłoński J. TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients. Arch Immunol Ther Exp (Warsz) 2001; 49 (1) 63-69
  Google Scholar
• 40 Schaider H, Oka M, Bogenrieder T , et al. Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int J Cancer 2003; 103 (3) 335-343
  CrossrefPubMedGoogle Scholar
• 41 Shamamian P, Schwartz JD, Pocock BJ , et al. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol 2001; 189 (2) 197-206
  CrossrefPubMedGoogle Scholar
• 42 Scapini P, Nesi L, Morini M , et al. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. J Immunol 2002; 168 (11) 5798-5804
  CrossrefPubMedGoogle Scholar
• 43 Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454 (7203): 436-444
  CrossrefGoogle Scholar
• 44 Rabinowich H, Cohen R, Bruderman I, Steiner Z, Klajman A. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Cancer Res 1987; 47 (1) 173-177
  PubMedGoogle Scholar
• 45 Cho H, Hur HW, Kim SW , et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 2009; 58 (1) 15-23
  CrossrefPubMedGoogle Scholar
• 46 Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 2007; 73 (3Y4): 215-220
  CrossrefGoogle Scholar
• 47 Petrie HT, Klassen LW, Kay HD. Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol 1985; 134 (1) 230-234
  PubMedGoogle Scholar
• 48 el-Hag A, Clark RA. Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system. J Immunol 1987; 139 (7) 2406-2413
  PubMedGoogle Scholar